Cbd dosage in clinical studies
Pro Research Analysisby 
Searched over 200M research papers
CBD Dosage Ranges in Clinical Studies
Clinical studies have used a wide range of cannabidiol (CBD) dosages, depending on the medical condition being treated. For epilepsy, especially treatment-resistant forms, studies commonly use high doses ranging from 10 to 50 mg/kg/day, with an average of about 15 mg/kg/day in randomized controlled trials. These higher doses have consistently shown positive effects in reducing seizure frequency and severity, and there is a clear linear relationship between higher CBD doses, higher plasma levels, and better seizure control in both adults and children, although children may respond to lower doses than adults Millar2019Wang2024Szaflarski2019+1 MORE.
For other conditions such as anxiety, psychotic disorders, and substance use disorders, the dosages are generally lower and more variable. Studies have used single or repeated doses ranging from as low as 6 mg up to 400 mg per day, with therapeutic benefits becoming more evident at doses of 300 mg or higher. Lower doses (below 300 mg/day) have shown less consistent results, particularly for insomnia, neurological disorders, and chronic pain Millar2019Arnold2022Larsen2020+1 MORE.
Efficacy and Safety of Low vs. High CBD Doses
High-dose CBD (10–50 mg/kg/day) is well-supported for epilepsy, while lower doses (up to 400 mg/day) are more commonly studied for anxiety and related disorders. In anxiety studies, doses between 6 mg and 400 mg per dose have been used, with improvements in clinical outcomes and minimal adverse effects, mainly fatigue and sedation. However, the evidence for efficacy at the lower end of this range is less robust, and more consistent benefits are seen at 300 mg or above Arnold2022Larsen2020Skelley2019.
For insomnia, a study using 150 mg nightly found that CBD was similar to placebo for most sleep outcomes, though it did improve subjective well-being, suggesting that psychological effects may be more prominent at this dose. The study emphasized the need for further research with different doses and longer treatment periods .
Formulation Differences and the "Entourage Effect"
Some studies have compared purified CBD to CBD-rich cannabis extracts. Patients using CBD-rich extracts for epilepsy reported improvements at lower average doses (about 6 mg/kg/day) compared to those using purified CBD (about 25 mg/kg/day). CBD-rich extracts also had fewer reports of adverse effects, suggesting a possible synergistic "entourage effect" from other cannabis compounds, though this requires further confirmation in controlled trials .
Pharmacokinetics and Special Populations
CBD is generally well tolerated across studies, with mild side effects. However, in patients with moderate to severe hepatic impairment, CBD exposure increases significantly, indicating that lower starting doses and slower titration are necessary for these individuals .
Summary of Key Dosage Findings
- Epilepsy: 10–50 mg/kg/day (average 15 mg/kg/day) is effective and well tolerated Millar2019Wang2024Szaflarski2019+1 MORE.
- Anxiety and Psychotic Disorders: 6–400 mg per dose, with clearer benefits at ≥300 mg/day Arnold2022Larsen2020Skelley2019.
- Insomnia: 150 mg nightly showed limited sleep benefits but improved well-being .
- CBD-Rich Extracts: May be effective at lower doses and with fewer side effects than purified CBD .
- Hepatic Impairment: Requires dose adjustment due to increased CBD exposure .
Conclusion
CBD dosing in clinical studies varies widely by condition, with high doses needed for epilepsy and moderate doses for anxiety and related disorders. While CBD is generally safe and well tolerated, more research is needed to determine optimal dosing for conditions beyond epilepsy, especially at lower doses and in special populations. Standardized dosing strategies and larger, robust clinical trials are essential for clearer guidance Millar2019Arnold2022Larsen2020+1 MORE.
Sources and full results
Most relevant research papers on this topic